China Food and Drug Administration, Decision on Revising Matters Relevant to the Administration of the Registration of Imported Pharmaceuticals (Draft for Comments)

国家食品药品监督管理总局关于调整进口药品注册管理有关事项的决定 (征求意见稿)

| BY

Susan Mok &clp articles

Issued: March 17 2017 Main contents: With a view to encouraging the simultaneous conduct of foreign and domestic clinical trials, after approval,…

Issued: March 17 2017

 

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]